Global Clinical Laboratory Tests Market Size & Outlook
Global clinical laboratory tests market, 2018-2030 (US$M)
Related Markets
Global clinical laboratory tests market highlights
- The global clinical laboratory tests market generated a revenue of USD 114,628.3 million in 2023 and is expected to reach USD 213,044.8 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 9.3% by 2030.
- In terms of segment, hba1c tests accounted for a revenue of USD 14,091.5 million in 2023.
- HGB/HCT tests is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 114,628.3 million |
| Market revenue in 2030 | USD 213,044.8 million |
| Growth rate | 9.3% (CAGR from 2023 to 2030) |
| Largest segment | Hba1c tests |
| Fastest growing segment | HGB/HCT tests |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Complete blood count, HGB/HCT tests, Basic metabolic panel, BUN creatinine tests, Electrolytes testing, HbA1c tests, Comprehensive metabolic panel tests, Liver panel tests, Renal panel tests, Lipid panel tests |
Other key industry trends
- In terms of revenue, the North America accounted for 48.8% of the global clinical laboratory tests market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, U.S. is the fastest growing regional market and is projected to reach USD 77,813.9 million by 2030.
Hba1c tests was the largest segment with a revenue share of 12.29% in 2023. Horizon Databook has segmented the Global clinical laboratory tests market based on complete blood count, hgb/hct tests, basic metabolic panel, bun creatinine tests, electrolytes testing, hba1c tests, comprehensive metabolic panel tests, liver panel tests, renal panel tests, lipid panel tests covering the revenue growth of each sub-segment from 2018 to 2030.
Growing prevalence of target diseases, such as cardiovascular diseases and diabetes, is anticipated to boost the market over the forecast period. Cardiovascular diseases are fatal and a leading cause of death worldwide.
Cardiovascular diseases have been a leading cause of mortality and morbidity worldwide in the last three decades. According to WHO, by 2030, cardiovascular diseases are anticipated to cause approximately 23.3 million deaths. Growing prevalence of lifestyle-associated diseases, such as obesity, increasing trend of smoking globally.
Moreover, the global prevalence of diabetes is also increasing, widening the patient pool for point-of-care lipid tests market. The table below highlights the prevalence of diabetes.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Laboratory Tests Market Scope
Clinical Laboratory Tests Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global clinical laboratory tests market size, by regions, 2018-2030 (US$M)
Top 10 countries: Clinical laboratory tests market size, 2023 (US$M)
Global clinical laboratory tests market share, by type, 2023 & 2030 (%, US$M)
Clinical laboratory tests market: Opportunity assessment by country
Global clinical laboratory tests market, by region, 2023 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
